Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease
- PMID: 3155875
- DOI: 10.1126/science.3155875
Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease
Abstract
Golgi impregnations of neostriatum from deceased Huntington's disease patients and controls were examined. In all cases of Huntington's disease the morphology of dendrites of medium-sized spiny neurons was markedly altered by the appearance of recurved endings and appendages, a decrease or increase in the density of spines, and abnormalities in the size and shape of spines. Pathological changes were rarely observed in medium-sized and large aspiny neostriatal neurons. The findings provide evidence for simultaneous degeneration and growth of spiny neurons in Huntington's disease and support the view that a specific population of neostriatal neurons is selectively involved in its pathogenesis.
Similar articles
-
Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry.J Neurosci. 1991 Dec;11(12):3877-87. doi: 10.1523/JNEUROSCI.11-12-03877.1991. J Neurosci. 1991. PMID: 1836019 Free PMC article.
-
Striatal interneurons in Huntington's disease: selective increase in the density of calretinin-immunoreactive medium-sized neurons.Mov Disord. 1996 Nov;11(6):619-26. doi: 10.1002/mds.870110605. Mov Disord. 1996. PMID: 8914086
-
[Huntington disease: 7 cases with relatively preserved neostriatal islets].Rev Neurol (Paris). 1992;148(2):107-16. Rev Neurol (Paris). 1992. PMID: 1534925 Review. French.
-
The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.Brain. 2007 Jan;130(Pt 1):222-32. doi: 10.1093/brain/awl332. Epub 2006 Dec 2. Brain. 2007. PMID: 17142832
-
Mitochondrial fragmentation in neuronal degeneration: Toward an understanding of HD striatal susceptibility.Biochem Biophys Res Commun. 2017 Feb 19;483(4):1063-1068. doi: 10.1016/j.bbrc.2016.08.042. Epub 2016 Aug 8. Biochem Biophys Res Commun. 2017. PMID: 27514446 Review.
Cited by
-
Nuclear Transport Deficits in Tau-Related Neurodegenerative Diseases.Front Neurol. 2020 Sep 25;11:1056. doi: 10.3389/fneur.2020.01056. eCollection 2020. Front Neurol. 2020. PMID: 33101165 Free PMC article. Review.
-
Alteration of Autophagy and Glial Activity in Nilotinib-Treated Huntington's Disease Patients.Metabolites. 2022 Dec 6;12(12):1225. doi: 10.3390/metabo12121225. Metabolites. 2022. PMID: 36557263 Free PMC article.
-
Beneficial behavioral effects of chronic cerebral dopamine neurotrophic factor (CDNF) infusion in the N171-82Q transgenic model of Huntington's disease.Sci Rep. 2023 Feb 20;13(1):2953. doi: 10.1038/s41598-023-28798-4. Sci Rep. 2023. PMID: 36807563 Free PMC article.
-
Evaluation of histone deacetylases as drug targets in Huntington's disease models. Study of HDACs in brain tissues from R6/2 and CAG140 knock-in HD mouse models and human patients and in a neuronal HD cell model.PLoS Curr. 2010 Sep 2;2:RRN1172. doi: 10.1371/currents.RRN1172. PLoS Curr. 2010. PMID: 20877454 Free PMC article.
-
Selective frontoinsular von Economo neuron and fork cell loss in early behavioral variant frontotemporal dementia.Cereb Cortex. 2012 Feb;22(2):251-9. doi: 10.1093/cercor/bhr004. Epub 2011 Jun 8. Cereb Cortex. 2012. PMID: 21653702 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical